Anastrozole
NDC 24979-725, Anastrozole Tablets, tablet, from Upsher-Smith Laboratories, LLC.
- Product NDC
- 24979-725
- Status
- Listed
- Labeler
- Upsher-Smith Laboratories, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206037
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/24979-725 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ANASTROZOLE1 mg/1
Pharmacologic classes
Aromatase Inhibitor [EPC]; Aromatase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 24979-725-06 | 24979072506 | 30 TABLET in 1 BOTTLE (24979-725-06) |
| 24979-725-07 | 24979072507 | 90 TABLET in 1 BOTTLE (24979-725-07) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7e0bd2cc-d3cc-403f-a6b6-4597ccb2f685
Use it
Look up 24979-725 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/24979-725 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 24979-725. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.